A Dose Escalation Study of RO6874813 in Participants With Locally Advanced or Metastatic Solid Tumors

NCT02558140 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

BIOLOGICAL: RO6874813
BIOLOGICAL: RO6874813

Sponsor

Hoffmann-La Roche